Skip to content

Single Incision Laparoscopic Colorectal Surgery

Single Incision Laparoscopic Surgery (SILS) for Colorectal Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03151733
Acronym
SILCS
Enrollment
200
Registered
2017-05-12
Start date
2017-06-28
Completion date
2024-06-29
Last updated
2024-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Colorectal Surgery

Keywords

SILS, colorectal cancer

Brief summary

Single incision laparoscopic surgery (SILS) is the further development of the concept of minimally invasive surgery for colorectal cancer,which rapidly developed in the field of colorectal surgery. Through the development of single hole laparoscopic colorectal cancer radical surgery and clinical study and follow up accordingly, evaluating the feasibility, surgical effectiveness and economy help to promote the popularization and application of single hole laparoscopic techniques in the field.

Detailed description

The patients with colorectal cancer will randomly divided into single incision laparoscopic surgery group and conditional laparoscopic surgery group. The operation time, blood loss, the incidence of lymph node , the number of postoperative complications, the gastrointestinal function recovery time, postoperative hospital stay,the number of local recurrence and distant metastasis, survival rate and the total cost of hospitalization will be evaluated to confirm the feasibility of single incision laparoscopic surgery is effective and economical. It is worthy of clinical application.

Interventions

Patients undergo single incision laparoscopic surgery

Patients undergo conventional laparoscopic surgery

Sponsors

Ruijin Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18 years \< age \< 80 years * Tumor located in colon and high rectum ( the lower border of the tumor is above the peritoneal reflection) * Pathological colorectal carcinoma * Clinically diagnosed cT1-4aN0-2 M0 lesions according to the 7th Edition of AJCC Cancer Staging Manual * Tumor size of 5 cm or less * ECOG score is 0-1 * ASA score is Ⅰ-Ⅲ * Informed consent

Exclusion criteria

* Body mass index (BMI) \>30 kg/m2 * The lower border of the tumor is located distal to the peritoneal reflection * Pregnant woman or lactating woman * Severe mental disease * Previous abdominal surgery(except appendectomy and cholecystotomy) * Emergency operation due to complication (bleeding, perforation or obstruction) caused by colorectal cancer * Requirement of simultaneous surgery for other disease

Design outcomes

Primary

MeasureTime frameDescription
Early morbidity rate30 daysmorbidity rate 30 days after surgery

Secondary

MeasureTime frameDescription
Intraoperative blood lossintraoperativeEstimated blood loss(milliliters,ml)
Incision lengthintraoperativeIncision length(centimeters,cm)
Lymph node detection14 days after surgeryLymph nodes harvested(numbers)
Incisal margin14 days after surgeryLength of proximal and distal margin (centimeters,cm)
Tumor size14 days after surgeryThe diameter of tumors(centimeters,cm)
Operative timeintraoperativeOperative time(minutes)
Postoperative recovery course1-14 days after surgeryTime to first ambulation, flatus, liquid diet and soft diet (hours after surgery)
Pain score1-3 days after surgeryPostoperative pain is recorded using the visual analog scale (VAS) pain score (0-10 points)tool on postoperative day 1, 2, 3 and the day of discharge
3-year disease free survival rate36 months after surgery3-year disease free survival rate
5-year overall survival rate60 months after surgery5-year overall survival rate
Length of stay1-14 days after surgeryDuration of hospital stay(days after surgery)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026